Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 59 citing articles:

The serotonin theory of depression: a systematic umbrella review of the evidence
Joanna Moncrieff, Ruth Cooper, Tom Stockmann, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 8, pp. 3243-3256
Open Access | Times Cited: 619
Major Depression and Its Recurrences: Life Course Matters
Scott M. Monroe, Kate L. Harkness
Annual Review of Clinical Psychology (2022) Vol. 18, Iss. 1, pp. 329-357
Open Access | Times Cited: 289
Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials
Arman Shafiee, Kyana Jafarabady, Niloofar Seighali, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 25
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Adele Framer
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 56
A cultural-ecosocial systems view for psychiatry
Ana Gómez-Carrillo, Laurence J. Kirmayer
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 30
Antidepressant Discontinuation Syndrome
Se Hyun Kim, Yong Sik Kim, Ung Gu Kang
Journal of Korean Neuropsychiatric Association (2024) Vol. 63, Iss. 2, pp. 104-104
Open Access | Times Cited: 12
Comparison of effectiveness and side effects of selegiline transdermal system versus oral monoamine oxidase inhibitors and tricyclic antidepressants for treatment-resistant depression
Thomas T. Kim, Colin Xu, Jay D. Amsterdam
Journal of Affective Disorders (2025) Vol. 376, pp. 47-51
Closed Access | Times Cited: 1
When Anxiety and Depression Coexist: The Role of Differential Diagnosis Using Clinimetric Criteria
Fiammetta Cosci, Giovanni A. Fava
Psychotherapy and Psychosomatics (2021) Vol. 90, Iss. 5, pp. 308-317
Open Access | Times Cited: 48
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Chiara Gastaldon, Georgios Schoretsanitis, Elena Arzenton, et al.
Drug Safety (2022) Vol. 45, Iss. 12, pp. 1539-1549
Open Access | Times Cited: 34
Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction
Deepak Rathour, Shruti Shah, Sabiya Khan, et al.
Behavioural Brain Research (2022) Vol. 436, pp. 114081-114081
Closed Access | Times Cited: 33
Pharmacological treatments in panic disorder in adults: a network meta-analysis
Giuseppe Guaiana, Nick Meader, Corrado Barbui, et al.
Cochrane library (2023) Vol. 2023, Iss. 11
Open Access | Times Cited: 14
Do antidepressants prevent transition to psychosis in individuals at clinical high-risk (CHR-P)? Systematic review and meta-analysis
Andrea Raballo, Michele Poletti, Antonio Preti
Psychological Medicine (2022) Vol. 53, Iss. 10, pp. 4550-4560
Closed Access | Times Cited: 19
The serotonin hypothesis of depression: both long discarded and still supported?
Joanna Moncrieff, Ruth Cooper, Tom Stockmann, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3160-3163
Open Access | Times Cited: 12
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials
Markus Dold, Hans‐Jürgen Möller, Hans‐Peter Volz, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 4
Können Antidepressiva den langfristigen Verlauf depressiver Erkrankungen negativ verändern?
Gerhard Gründer, Lea J. Mertens, Moritz Spangemacher, et al.
Der Nervenarzt (2025)
Closed Access
Cognitive Enhancement and Brain Plasticity in Mental Health
Haley V. West, Megan K. Finnegan, Maya A. Marder, et al.
Oxford University Press eBooks (2025)
Closed Access
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study
Peter C. Groot, Jim van Os
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 26
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
Stefania Chiappini, Rachel Vickers‐Smith, Amira Guirguis, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 565-565
Open Access | Times Cited: 17
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Markus Dold, Lucie Bartova, Hans‐Peter Volz, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1615-1628
Open Access | Times Cited: 10
The need for antidepressant withdrawal support services: Recommendations from 708 patients
John Read, Stevie Lewis, Mark Horowitz, et al.
Psychiatry Research (2023) Vol. 326, pp. 115303-115303
Open Access | Times Cited: 10
Coadministration of scopolamine and mGlu2 receptor negative allosteric modulator VU6001966 as a potential therapeutic approach for depression: Rat frontal cortex neurochemistry and behavior
Yana Babii, Agnieszka Pałucha-Poniewiera, Krystyna Gołembiowska, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 250, pp. 173996-173996
Closed Access
Stage models for major depression: Cognitive behavior therapy, mechanistic treatment targets, and the prevention of stage transition
Michael W. Otto, Jeffrey L. Birk, Hayley E. Fitzgerald, et al.
Clinical Psychology Review (2022) Vol. 95, pp. 102172-102172
Open Access | Times Cited: 14
The serotonin theory of depression
Rif S. El‐Mallakh, Masoud Doroodgar, Omar H. Elsayed, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3157-3157
Closed Access | Times Cited: 8
Outcomes of hyperbolic tapering of antidepressants
Jim van Os, Peter C. Groot
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top